▲ President Tae Won Kim of AMC Cancer Institute (front row, center) and the participants of the Cancer Institute Symposium are taking a commemorative photo.

On September 1st, AMC Cancer Institute hosted its Cancer Institute Symposium entitled ‘Next-Generation Cancer Therapies: Precision and Innovation.’ This symposium drew more than 660 domestic and international medical professionals, all of whom were deeply impressed by the specialized sessions presented by world-renowned scholars, which included the following topics: ‘Moving Forward with Precision Oncology in Breast Cancer’ presented by Professor Prue Francis from the Peter MacCallum Cancer Center in Australia, ‘PARPi, ADCs, and Other Targets in Epithelial Ovarian Cancer’ by Professor Angeles A. Secord from Duke Cancer Institute in the USA, and ‘Carbon-ion Radiotherapy; the Past, Present, and Future’ delivered by Professor Hitoshi Ishikawa from QST Hospital in Japan.

Subsequent to these sessions, discussions were conducted under the overarching theme of ‘Innovation for the Future.’ This segment encompassed presentations and dialogues on subjects such as ‘Digital Innovation and Compliance in Precision Oncology’ and ‘Our Response Strategies in the Era of Mega AI and Its Impact on the Medical Field.’ Furthermore, specialized cancer sessions were convened for lung, breast, gynecologic, and head and neck cancers, providing a platform for sharing the latest advancements and insights. The program also featured lectures and Q&A sessions addressing the quality of life concerns of cancer patients.

President Tae Won Kim of AMC Cancer Institute expressed his thoughts on the event, stating, "At the Cancer Institute Symposium, we delved into the current state of cancer treatment and contemplated its future. This event held particular significance as it marked our return to face-to-face arrangements since the onset of COVID-19." He went on to say, "I anticipate that the symposium will foster in-depth discussions on new treatments in precision medicine and explore the ways in which AI can be harnessed to enhance the field of medicine."